Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eed2c1b329fa4c3c0472f146ca907bbe |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-30062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2310-00293 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-2817 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-30677 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0063 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00 |
filingDate |
2000-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a97be9596173415bb44f65c74cf2e4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31c5a31b3b9da7b94b3fb2c83d7817c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfd204c0f1f80e0474c18457dca04a64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1639f89254dd35cc9a509b8968d986a1 |
publicationDate |
2002-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1227851-A1 |
titleOfInvention |
Absorbable bone implant material and method for producing the same |
abstract |
The invention relates to absorbable bone implant material produced from a powder component containing hydroxylapatite; and a liquid. Said powder component of the implant material essentially consists of a mixture of hydroxylapatite powder and calcium sulphate powder. The hydroxylapatite powder consists of synthetically produced, precipitated, highly pure crystalline nano-particles with a crystal size of 10-20 nm in width and 50-60 nm in length. The specific absorbent BET surface area of the nano-crystals is preferably 100-150m2/g. |
priorityDate |
1999-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |